Ana Calle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ana Calle has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Ricardo Cardona
Universidad de Antioquia, Grupo de Alergología Clínica y Experimental, Medellín
6 shared publications - Jorge Sánchez
Group of Clinical and Experimental Allergy (GACE), Hospital “Alma Mater de Antioquia”, University of Antioquia, Medellín, Colombia
3 shared publications - Liliana Guevara-Saldaña
Universidad de Antioquía
3 shared publications - Luis Santamaría
Universidad de Antioquia, Grupo de Alergología Clínica y Experimental, Medellín
3 shared publications - Ana Acevedo
Clínic “Unidad Alergológica”, Medellín, Colombia
1 shared publication - Ana Elizabeth Sipols
Department of Applied Mathematics, Materials Science and Engineering and Electronic Technology, Rey Juan Carlos University, Madrid, Spain
1 shared publication
Latest Publications
- 14 May 2024
- Published by Taylor & Francis in Immunotherapy
- Vol. 16 (9) , 623-634
Selection of allergen extract for immunotherapy in polysensitized allergic rhinitis patients
Aim: To evaluate the criteria used by allergists in selecting an immunotherapy extract (allergen immunotherapy [AIT]-extract) in rhinitis patients with polysensitization. Methods: First, a cross-sectional study was carried out by evaluating different factors that influence the medical choice of AIT-extract. Second, a literature review was performed by evaluating the diagnostic performance of atopy tests. Results: A total of 419 patients were included (84 children, 149 adolescents and 186 adults). Anamnesis, atopy tests and exposure to pets were the main factors for choosing the AIT extract. The sensitivity and specificity of atopy tests were high for Dermatophagoides spp., (>80%), moderate for pets (60%) and indeterminate for Blomia tropicalis. Conclusion: NCTs could be necessary for AIT-extract selection in polysensitized allergic rhinitis patients.
- 14 May 2024
- Published by Taylor & Francis in Immunotherapy
- Vol. 16 (9) , 623-634
Selection of allergen extract for immunotherapy in polysensitized allergic rhinitis patients
Aim: To evaluate the criteria used by allergists in selecting an immunotherapy extract (allergen immunotherapy [AIT]-extract) in rhinitis patients with polysensitization. Methods: First, a cross-sectional study was carried out by evaluating different factors that influence the medical choice of AIT-extract. Second, a literature review was performed by evaluating the diagnostic performance of atopy tests. Results: A total of 419 patients were included (84 children, 149 adolescents and 186 adults). Anamnesis, atopy tests and exposure to pets were the main factors for choosing the AIT extract. The sensitivity and specificity of atopy tests were high for Dermatophagoides spp., (>80%), moderate for pets (60%) and indeterminate for Blomia tropicalis. Conclusion: NCTs could be necessary for AIT-extract selection in polysensitized allergic rhinitis patients.
- Top Cited PapersOpen Access
- 7 April 2023
- Published by Elsevier in World Allergy Organization Journal
- Vol. 16 (3) , 100673
DRESS syndrome: A literature review and treatment algorithm
- 7 April 2023
- Published by Elsevier in World Allergy Organization Journal
- Vol. 16 (3) , 100673
Top Cited PapersOpen AccessDRESS syndrome: A literature review and treatment algorithm
- Open Access
- 7 June 2021
- Published by Colegio Mexicano de Inmunologia Clinica y Alergia, A. C. in Revista Alergia México
- Vol. 68 (1) , 35-47
Hipersensibilidad a antibióticos betalactámicos: algoritmos de manejo y desensibilización como alternativa terapéutica vital
Las reacciones de hipersensibilidad pueden ser complejas y poner en peligro la vida de los pacientes, más cuando se involucran medicamentos como los antibióticos betalactámicos. A la fecha, se dispone de algoritmos diagnósticos y aplicaciones móviles que facilitan el abordaje clínico, así como pruebas de laboratorio y procedimientos más especializados, como las pruebas cutáneas y de exposición controlada, útiles para la identificación de la sustancia implicada y para la selección de alternativas terapéuticas seguras y efectivas. Desde hace varios años, el procedimiento de desensibilización se ha posicionado como una herramienta vital para el alergólogo clínico y los pacientes, y es clave para mejorar los desenlaces clínicos, tanto la supervivencia como la calidad de vida.
- 7 June 2021
- Published by Colegio Mexicano de Inmunologia Clinica y Alergia, A. C. in Revista Alergia México
- Vol. 68 (1) , 35-47
Open AccessHipersensibilidad a antibióticos betalactámicos: algoritmos de manejo y desensibilización como alternativa terapéutica vital
Las reacciones de hipersensibilidad pueden ser complejas y poner en peligro la vida de los pacientes, más cuando se involucran medicamentos como los antibióticos betalactámicos. A la fecha, se dispone de algoritmos diagnósticos y aplicaciones móviles que facilitan el abordaje clínico, así como pruebas de laboratorio y procedimientos más especializados, como las pruebas cutáneas y de exposición controlada, útiles para la identificación de la sustancia implicada y para la selección de alternativas terapéuticas seguras y efectivas. Desde hace varios años, el procedimiento de desensibilización se ha posicionado como una herramienta vital para el alergólogo clínico y los pacientes, y es clave para mejorar los desenlaces clínicos, tanto la supervivencia como la calidad de vida.
- Open Access
- 1 September 2020
- Published by Elsevier in World Allergy Organization Journal
- Vol. 13 (9)
Nasal specific IgE to Der p is not an acceptable screening test to predict the outcome of the nasal challenge test in patients with non-allergic rhinitis
- 1 September 2020
- Published by Elsevier in World Allergy Organization Journal
- Vol. 13 (9)
Open AccessNasal specific IgE to Der p is not an acceptable screening test to predict the outcome of the nasal challenge test in patients with non-allergic rhinitis
- Open Access
- 29 April 2020
- Published by Colegio Mexicano de Inmunologia Clinica y Alergia, A. C. in Revista Alergia México
- Vol. 67 (1) , 54-61
Estado actual del conocimiento en rinitis alérgica local
In recent years, a new phenotype of rhinitis has been described; it is characterized by the local production of specific IgE. There isn’t any evidence of systemic atopy and it has been called local allergic rhinitis. Understanding the involved physiopathological mechanisms and the behavior of this phenotype translates into the development of strategies and treatments that improve the quality of life of patients with this disease. Below, we present an updated review of the available information regarding this disease and also of the aspects that are yet unresolved.
- 29 April 2020
- Published by Colegio Mexicano de Inmunologia Clinica y Alergia, A. C. in Revista Alergia México
- Vol. 67 (1) , 54-61
Open AccessEstado actual del conocimiento en rinitis alérgica local
In recent years, a new phenotype of rhinitis has been described; it is characterized by the local production of specific IgE. There isn’t any evidence of systemic atopy and it has been called local allergic rhinitis. Understanding the involved physiopathological mechanisms and the behavior of this phenotype translates into the development of strategies and treatments that improve the quality of life of patients with this disease. Below, we present an updated review of the available information regarding this disease and also of the aspects that are yet unresolved.
- Open Access
- 9 April 2019
- Published by Colegio Mexicano de Inmunologia Clinica y Alergia, A. C. in Revista Alergia México
- Vol. 66 (3) , 366-370
Erupción polimorfa del embarazo, un diagnóstico diferencial de las reacciones graves por medicamentos
Background: The polymorphic eruption of pregnancy (PEP) is a pathology that usually occurs in the last trimester of pregnancy and it affects around 0.5% pregnancies. So far, it has not been associated to medications, but it could mimic any severe delayed reaction to drugs.Clinical case: A woman with a clinical picture that suggests PEP during the last trimester of pregnancy. She was assessed by the allergy department, where it was viewed as PEP; however, the decision was to perform skin tests: skin prick tests, intradermal tests, and skin patch tests with drugs involved; all of which showed negative results.Conclusions: Severe reactions to medications are a challenge for health professionals. In acute management, the identification and suspension of the involved medication are the cornerstones of the treatment; however, many of the patients are polymedicated, which makes it difficult to identify the underlying cause. An allergy assessment is recommended as part of the optimal multidisciplinary management of each patient in order to identify the substance that is involved as the cause of the disease and, therefore, to avoid unnecessary restrictions.
- 9 April 2019
- Published by Colegio Mexicano de Inmunologia Clinica y Alergia, A. C. in Revista Alergia México
- Vol. 66 (3) , 366-370
Open AccessErupción polimorfa del embarazo, un diagnóstico diferencial de las reacciones graves por medicamentos
Background: The polymorphic eruption of pregnancy (PEP) is a pathology that usually occurs in the last trimester of pregnancy and it affects around 0.5% pregnancies. So far, it has not been associated to medications, but it could mimic any severe delayed reaction to drugs.Clinical case: A woman with a clinical picture that suggests PEP during the last trimester of pregnancy. She was assessed by the allergy department, where it was viewed as PEP; however, the decision was to perform skin tests: skin prick tests, intradermal tests, and skin patch tests with drugs involved; all of which showed negative results.Conclusions: Severe reactions to medications are a challenge for health professionals. In acute management, the identification and suspension of the involved medication are the cornerstones of the treatment; however, many of the patients are polymedicated, which makes it difficult to identify the underlying cause. An allergy assessment is recommended as part of the optimal multidisciplinary management of each patient in order to identify the substance that is involved as the cause of the disease and, therefore, to avoid unnecessary restrictions.
- Open Access
- 4 April 2019
- Published by Colegio Mexicano de Inmunologia Clinica y Alergia, A. C. in Revista Alergia México
- Vol. 66 (1) , 123-127
Anafilaxia en lactante alérgica a la proteína de la leche de vaca
Background: Allergy to cow’s milk protein is a common problem in children. The clinical manifestations of the reactions that are mediated by IgE are varied and the anaphylactic reactions can be life-threatening.Clinical case: A girl at an age of four months and a half that, five minutes after consuming cereal with cow’s milk, had rashes in the perioral area and extensive pruritic micropapular lesions associated with vomit and inspiratory stridor. She received adrenaline by intramuscular injection and antihistamines by intravenous injection. She was first evaluated in a service of allergy treatment when she was six months and twenty days old. The results of the allergen-specific immunoglobulin E test were positive. The treatment was initiated with a hydrolyzed rice formula and supplementary feeding.Conclusions: Anaphylaxis can be the first and last manifestation of a food allergy. The right education for parents about strictly avoiding the food that triggered the allergic reaction and the right training in the use of intramuscular adrenalin may result in a better prognosis for patients.
- 4 April 2019
- Published by Colegio Mexicano de Inmunologia Clinica y Alergia, A. C. in Revista Alergia México
- Vol. 66 (1) , 123-127
Open AccessAnafilaxia en lactante alérgica a la proteína de la leche de vaca
Background: Allergy to cow’s milk protein is a common problem in children. The clinical manifestations of the reactions that are mediated by IgE are varied and the anaphylactic reactions can be life-threatening.Clinical case: A girl at an age of four months and a half that, five minutes after consuming cereal with cow’s milk, had rashes in the perioral area and extensive pruritic micropapular lesions associated with vomit and inspiratory stridor. She received adrenaline by intramuscular injection and antihistamines by intravenous injection. She was first evaluated in a service of allergy treatment when she was six months and twenty days old. The results of the allergen-specific immunoglobulin E test were positive. The treatment was initiated with a hydrolyzed rice formula and supplementary feeding.Conclusions: Anaphylaxis can be the first and last manifestation of a food allergy. The right education for parents about strictly avoiding the food that triggered the allergic reaction and the right training in the use of intramuscular adrenalin may result in a better prognosis for patients.
- Open Access
- 5 September 2018
- Published by Colegio Mexicano de Inmunologia Clinica y Alergia, A. C. in Revista Alergia México
- Vol. 65 (4) , 431-436
Anafilaxia por clorhexidina en un contexto perioperatorio: diagnóstico y manejo
Background: During surgery, the patient is exposed to multiple medications and molecules that can be associated with the development hypersensitivity, which makes it difficult to detect the causative agent of a perioperative reaction and makes it necessary to perform allergy tests.Case report: 53-year-old man who after a right knee arthroscopy was administered intravenous ketorolac; at 12 minutes, a pruriginous rash appeared on the chest, abdomen and limbs; infusion of the drug was immediately stopped and 100 mg intravenous hydrocortisone were administered. At 15 minutes, the patient experienced bilateral angioedema of the eyelids and a sensation of breathlessness, and oxygen was therefore administered, as well as 2 mg intravenous clemastine, 5 mg intravenous ranitidine and 20 µg subcutaneous adrenaline. Epidermal tests with 0.5 % chlorhexidine and serum chlorhexidine-specific immunoglobulin E (IgE) were performed, both with positive results. The patient recovered without complications; at discharge, he was prescribed intramuscular etofenamate.Conclusion: Perioperative anaphylaxis is a rare, but potentially fatal event. Proper identification of the drug or substance responsible for the reaction by using allergy tests decreases unnecessary pharmacological restrictions and avoids re-exposure.
- 5 September 2018
- Published by Colegio Mexicano de Inmunologia Clinica y Alergia, A. C. in Revista Alergia México
- Vol. 65 (4) , 431-436
Open AccessAnafilaxia por clorhexidina en un contexto perioperatorio: diagnóstico y manejo
Background: During surgery, the patient is exposed to multiple medications and molecules that can be associated with the development hypersensitivity, which makes it difficult to detect the causative agent of a perioperative reaction and makes it necessary to perform allergy tests.Case report: 53-year-old man who after a right knee arthroscopy was administered intravenous ketorolac; at 12 minutes, a pruriginous rash appeared on the chest, abdomen and limbs; infusion of the drug was immediately stopped and 100 mg intravenous hydrocortisone were administered. At 15 minutes, the patient experienced bilateral angioedema of the eyelids and a sensation of breathlessness, and oxygen was therefore administered, as well as 2 mg intravenous clemastine, 5 mg intravenous ranitidine and 20 µg subcutaneous adrenaline. Epidermal tests with 0.5 % chlorhexidine and serum chlorhexidine-specific immunoglobulin E (IgE) were performed, both with positive results. The patient recovered without complications; at discharge, he was prescribed intramuscular etofenamate.Conclusion: Perioperative anaphylaxis is a rare, but potentially fatal event. Proper identification of the drug or substance responsible for the reaction by using allergy tests decreases unnecessary pharmacological restrictions and avoids re-exposure.